• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半胱天冬酶-1()联合多模态超声特征对乳腺癌患者预后的影响。 需注意,原文中“caspase-1 ()”括号内内容缺失,翻译可能会存在一定不准确,完整准确的翻译需补充完整该部分内容。

Effect of caspase-1 () combined with multimodal ultrasound features on the prognosis of breast cancer patients.

作者信息

Peng Juan, Wei Qiang, Zhou Shibo, Gu Zhutong, Lv Kangtai

机构信息

Department of Ultrasound, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Department of Ultrasound, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.

出版信息

Transl Cancer Res. 2023 Aug 31;12(8):2138-2154. doi: 10.21037/tcr-23-1135. Epub 2023 Aug 28.

DOI:10.21037/tcr-23-1135
PMID:37701103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10493798/
Abstract

BACKGROUND

Breast cancer (BRCA) is the malignant tumor with the highest incidence rate among women in the world, and its mortality rate ranks second. The purpose of our study is to explore the correlation between caspase-1 () and the prognosis of BRCA patients and the potential mechanism of action, and to analyze the clinical value of combined with multimodal ultrasound features in early screening and prognosis of BRCA.

METHODS

We analyzed The Cancer Genome Atlas (TCGA) database to confirm that was expressed in BRCA patients and determine whether its expression was correlated with patient prognosis. The relationship between expression and survival was measured by the clinicopathological parameters. Multivariate analysis was performed using Cox regression, and a nomogram was developed using these results for quality assurance purposes. The correlations between and immune cells were investigated using the Tumor Immune Estimation Resource (TIMER) and TCGA databases. Next, we performed gene set enrichment analysis (GSEA) to determine the potential mechanism of action. Finally, to analyze the effect of combined with multimodal ultrasonography characteristics on the prognosis of BRCA patients was studied by analyzing the clinical data of patients.

RESULTS

expression was lower in BRCA tumor tissues than in the surrounding tissues. Patients with high expression had better overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI) than those with low expression. GSEA suggested that may affect the cell cycle, immune environment, inflammation, apoptosis, the HIPPOMERLIN pathway, Natural killer (NK) cell regulation of cytotoxicity, p53 expression, the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway, the mitogen-activated protein kinase (MAPK) pathway, extracellular matrix, etc., thereby influencing the biological events in BRCA. Among conventional ultrasound features and contrast-enhanced ultrasound (CEUS) features, mass margin status and blood flow grade were associated with the expression of . Meanwhile, patients with poor ultrasound features tended to have low expression.

CONCLUSIONS

may be a novel predictive marker for BRCA patients. combined with multimodal ultrasound features has good clinical value in the early screening and prognostic prediction of BRCA.

摘要

背景

乳腺癌(BRCA)是全球女性中发病率最高的恶性肿瘤,其死亡率位居第二。本研究的目的是探讨半胱天冬酶 -1()与BRCA患者预后的相关性及其潜在作用机制,并分析其联合多模态超声特征在BRCA早期筛查和预后中的临床价值。

方法

我们分析了癌症基因组图谱(TCGA)数据库,以确认其在BRCA患者中的表达情况,并确定其表达是否与患者预后相关。通过临床病理参数测量其表达与生存之间的关系。使用Cox回归进行多变量分析,并利用这些结果绘制列线图以确保质量。使用肿瘤免疫评估资源(TIMER)和TCGA数据库研究其与免疫细胞之间的相关性。接下来,我们进行基因集富集分析(GSEA)以确定潜在的作用机制。最后,通过分析患者的临床数据,研究其联合多模态超声特征对BRCA患者预后的影响。

结果

BRCA肿瘤组织中的表达低于周围组织。高表达患者的总生存期(OS)、疾病特异性生存期(DSS)和无进展生存期(PFI)均优于低表达患者。GSEA表明,其可能影响细胞周期、免疫环境、炎症、凋亡、HIPPOMERLIN通路、自然杀伤(NK)细胞的细胞毒性调节、p53表达、Janus激酶 - 信号转导和转录激活因子(JAK - STAT)通路、丝裂原活化蛋白激酶(MAPK)通路、细胞外基质等,从而影响BRCA中的生物学事件。在传统超声特征和超声造影(CEUS)特征中,肿块边缘状态和血流分级与的表达相关。同时,超声特征较差的患者往往表达较低。

结论

可能是BRCA患者的一种新型预测标志物。其联合多模态超声特征在BRCA的早期筛查和预后预测中具有良好的临床价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/f1e75df0d492/tcr-12-08-2138-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/b48c3849d34a/tcr-12-08-2138-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/73a2f8d63cfd/tcr-12-08-2138-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/2891906686fa/tcr-12-08-2138-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/da51b4aad440/tcr-12-08-2138-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/b972ff896391/tcr-12-08-2138-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/8984c8c16287/tcr-12-08-2138-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/54e9b70fea3e/tcr-12-08-2138-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/f1e75df0d492/tcr-12-08-2138-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/b48c3849d34a/tcr-12-08-2138-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/73a2f8d63cfd/tcr-12-08-2138-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/2891906686fa/tcr-12-08-2138-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/da51b4aad440/tcr-12-08-2138-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/b972ff896391/tcr-12-08-2138-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/8984c8c16287/tcr-12-08-2138-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/54e9b70fea3e/tcr-12-08-2138-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a0d/10493798/f1e75df0d492/tcr-12-08-2138-f8.jpg

相似文献

1
Effect of caspase-1 () combined with multimodal ultrasound features on the prognosis of breast cancer patients.半胱天冬酶-1()联合多模态超声特征对乳腺癌患者预后的影响。 需注意,原文中“caspase-1 ()”括号内内容缺失,翻译可能会存在一定不准确,完整准确的翻译需补充完整该部分内容。
Transl Cancer Res. 2023 Aug 31;12(8):2138-2154. doi: 10.21037/tcr-23-1135. Epub 2023 Aug 28.
2
Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.一种基于新型锌指蛋白相关基因的乳腺癌预后模型的鉴定与验证
PeerJ. 2021 Oct 18;9:e12276. doi: 10.7717/peerj.12276. eCollection 2021.
3
Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma.尿激酶型纤溶酶原激活剂联合临床分期及巴塞罗那临床肝癌分期对肝细胞癌患者预后的影响。
J Gastrointest Oncol. 2023 Jun 30;14(3):1434-1450. doi: 10.21037/jgo-23-311.
4
Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.全面分析细胞因子信号转导抑制蛋白在人类乳腺癌中的作用。
BMC Cancer. 2021 Jun 13;21(1):696. doi: 10.1186/s12885-021-08434-y.
5
Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.泛癌分析揭示 DIP2B 在乳腺癌中的癌基因特征和预后价值。
BMC Cancer. 2023 Mar 31;23(1):296. doi: 10.1186/s12885-023-10751-3.
6
Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction.乳腺癌中C-X-C基序趋化因子受体的分析:免疫治疗及预后预测中的潜在价值
Ann Transl Med. 2022 Dec;10(24):1379. doi: 10.21037/atm-22-6056.
7
The expression landscape of FOXP3 and its prognostic value in breast cancer.FOXP3在乳腺癌中的表达情况及其预后价值
Ann Transl Med. 2022 Jul;10(14):801. doi: 10.21037/atm-22-3080.
8
Mining the prognostic significance and immune infiltration of family members in human breast cancer by bioinformatics analysis.通过生物信息学分析挖掘人类乳腺癌中家族成员的预后意义和免疫浸润情况。
Gland Surg. 2022 Apr;11(4):720-741. doi: 10.21037/gs-22-189.
9
CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.CCDC68预测结直肠癌患者预后不良:一项基于TCGA数据的研究
J Gastrointest Oncol. 2022 Apr;13(2):657-671. doi: 10.21037/jgo-22-148.
10
FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer.FN1过表达与乳腺癌的不良预后和免疫浸润相关。
Front Genet. 2022 Aug 12;13:913659. doi: 10.3389/fgene.2022.913659. eCollection 2022.

引用本文的文献

1
Profiling the Expression Level of a Gene from the Caspase Family in Triple-Negative Breast Cancer.分析半胱天冬酶家族中一个基因在三阴性乳腺癌中的表达水平。
Int J Mol Sci. 2025 Aug 1;26(15):7463. doi: 10.3390/ijms26157463.
2
Immunohistochemical Expression of Caspase1 and Epidermal Growth Factor Receptor in Invasive Breast Carcinoma and Their Biological and Prognostic Associations.免疫组织化学检测 Caspase1 和表皮生长因子受体在浸润性乳腺癌中的表达及其与生物学和预后的关系。
Asian Pac J Cancer Prev. 2024 Jul 1;25(7):2529-2537. doi: 10.31557/APJCP.2024.25.7.2529.

本文引用的文献

1
Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer and .伊帕司他滨在子宫内膜癌中表现出抗肿瘤作用,并增强了对紫杉醇的敏感性。
Int J Oncol. 2023 Sep;63(3). doi: 10.3892/ijo.2023.5551. Epub 2023 Jul 28.
2
Comparative study of pathological response evaluation systems after neoadjuvant chemotherapy for breast cancer: developing predictive models of multimodal ultrasound features including shear wave elastography combined with puncture pathology.乳腺癌新辅助化疗后病理反应评估系统的比较研究:建立包括剪切波弹性成像联合穿刺病理的多模态超声特征预测模型
Quant Imaging Med Surg. 2023 May 1;13(5):3013-3028. doi: 10.21037/qims-22-910. Epub 2023 Mar 31.
3
Multimodal ultrasound features of breast cancers: correlation with molecular subtypes.
乳腺癌的多模态超声特征:与分子亚型的相关性。
BMC Med Imaging. 2023 Apr 17;23(1):57. doi: 10.1186/s12880-023-00999-3.
4
Expression and clinical significance of undifferentiated embryonic cell transcription factor 1 in breast cancer.未分化胚胎细胞转录因子1在乳腺癌中的表达及临床意义
Transl Cancer Res. 2023 Jan 30;12(1):150-162. doi: 10.21037/tcr-22-2890. Epub 2023 Jan 13.
5
Upregulation of KHDC1L promotes the proliferation and inhibits apoptosis in head and neck squamous cell carcinoma.KHDC1L 的上调促进头颈部鳞状细胞癌的增殖并抑制凋亡。
Epigenetics. 2023 Dec;18(1):2175168. doi: 10.1080/15592294.2023.2175168. Epub 2023 Feb 3.
6
Comparison of ultrasound and mammography for early diagnosis of breast cancer among Chinese women with suspected breast lesions: A prospective trial.超声与钼靶 X 线摄影对中国疑似乳腺癌女性早期诊断作用的比较:一项前瞻性研究。
Thorac Cancer. 2022 Nov;13(22):3145-3151. doi: 10.1111/1759-7714.14666. Epub 2022 Sep 30.
7
Molecular Classification of Breast Cancer: Relevance and Challenges.乳腺癌的分子分类:意义与挑战。
Arch Pathol Lab Med. 2023 Jan 1;147(1):46-51. doi: 10.5858/arpa.2022-0070-RA.
8
Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis.超声造影在乳腺癌诊断中的临床价值。
Comput Math Methods Med. 2022 Sep 5;2022:2017026. doi: 10.1155/2022/2017026. eCollection 2022.
9
Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer.早期治疗转录谱分析作为改善HER2阳性炎性乳腺癌病理反应预测的工具。
Ther Adv Med Oncol. 2022 Jul 30;14:17588359221113269. doi: 10.1177/17588359221113269. eCollection 2022.
10
Combination of Focused Ultrasound, Immunotherapy, and Chemotherapy: New Perspectives in Breast Cancer Therapy.聚焦超声、免疫疗法与化疗的联合应用:乳腺癌治疗的新视角
J Ultrasound Med. 2023 Feb;42(3):559-573. doi: 10.1002/jum.16053. Epub 2022 Jul 23.